The Biden administration will distribute 400 million nonsurgical N95 masks; a study aims to develop a questionnaire to enable gay and bisexual men to donate blood; counterfeit versions of Gilead HIV treatments were discovered in 9 states.
The White House will announce Wednesday the United States will distribute 400 million nonsurgical N95 masks sourced from the federal Strategic National Stockpile, Politico reported. It aims to make these adult-sized masks available at tens of thousands of pharmacies and health centers across the country by early February, and is still working on a similar plan for child-sized masks. The administration also launched COVIDtests.gov this week for Americans to order up to 4 free rapid tests per household. Some apartment residents ran into issues placing these orders, but an administration official said this was not widespread and orders are being prioritized for people in higher-risk areas.
As reported by The Hill, a FDA-funded study is working to develop alternatives for gay and bisexual men who wish to donate blood to replace existing restrictions. The ADVANCE study will recruit 2000 gay or bisexual men across 8 cities to test the reliability of a donor history questionnaire based on individual HIV transmission risk. If successful, the questionnaire could replace the FDA’s current deferral policy that bars men from donating blood if they have had sexual contact with another man less than 3 months prior to donation. This news comes after the American Red Cross declared its first national blood crisis.
Gilead Sciences announced that an unauthorized network of drug suppliers sold counterfeit versions of its HIV treatment over the last 2 years, totaling $250 million, Reuters reported. Gilead found 85,247 tampered with or fake bottles of its Biktarvy and Descovy treatments. As part of an investigation, fake Gilead-labeled medications were seized from 17 locations in 9 states and identified unauthorized pharmaceutical distributors involved. The company believes that it has stopped any additional counterfeit products from these distributors from reaching patients.
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
Panel Addresses Minority Physician Shortage, Maternal Health, at Senate Committee Hearing
May 15th 2024The senate hearing held by the US Senate Committee on Health, Education, Labor, and Pensions, led by Sen. Bernie Sanders (I, Vermont), chairman of the committee, and ranking member Sen. Bill Cassidy, MD, (R, Louisiana), addressed the critical issue of physician and health care worker shortages, as well as the maternal health crisis, in the US.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Patients With MG Report Higher Azathioprine Discontinuation vs Other Immunosuppressants
May 15th 2024Survey data from over 200 patients showed that treatment discontinuation was lower for those taking mycophenolate or methotrexate than for those taking azathioprine for their myasthenia gravis (MG).
Read More